Increased MTH1-specific 8-oxodGTPase activity is a hallmark of cancer in colon, lung and pancreatic tissue

Lisa A. McPherson, Clara I. Troccoli, Debin Ji, Annie E. Bowles, Makelle L. Gardiner, Michael G. Mohsen, Nagaraj S. Nagathihalli, Dao M. Nguyen, David J. Robbins, Nipun B. Merchant, Eric T. Kool, Priyamvada Rai, James M. Ford

Research output: Contribution to journalArticle

Abstract

Cellular homeostasis is dependent on a balance between DNA damage and DNA repair mechanisms. Cells are constantly assaulted by both exogenous and endogenous stimuli leading to high levels of reactive oxygen species (ROS) that cause oxidation of the nucleotide dGTP to 8-oxodGTP. If this base is incorporated into DNA and goes unrepaired, it can result in G > T transversions, leading to genomic DNA damage. MutT Homolog 1 (MTH1) is a nucleoside diphosphate X (Nudix) pyrophosphatase that can remove 8-oxodGTP from the nucleotide pool before it is incorporated into DNA by hydrolyzing it into 8-oxodGMP. MTH1 expression has been shown to be elevated in many cancer cells and is thought to be a survival mechanism by which a cancer cell can stave off the effects of high ROS that can result in cell senescence or death. It has recently become a target of interest in cancer because it is thought that inhibiting MTH1 can increase genotoxic damage and cytotoxicity. Determining the role of MTH1 in normal and cancer cells is confounded by an inability to reliably and directly measure its native enzymatic activity. We have used the chimeric ATP-releasing guanine-oxidized (ARGO) probe that combines 8-oxodGTP and ATP to measure MTH1 enzymatic activity in colorectal cancer (CRC), non-small cell lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC) along with patient-matched normal tissue. MTH1 8-oxodGTPase activity is significantly increased in tumors across all three tissue types, indicating that MTH1 is a marker of cancer. MTH1 activity measured by ARGO assay was compared to mRNA and protein expression measured by RT-qPCR and Western blot in the CRC tissue pairs, revealing a positive correlation between ARGO assay and Western blot, but little correlation with RT-qPCR in these samples. The adoption of the ARGO assay will help in establishing the level of MTH1 activity in model systems and in assessing the effects of MTH1 modulation in the treatment of cancer.

Original languageEnglish (US)
Article number102644
JournalDNA Repair
DOIs
StatePublished - Jan 1 2019

Fingerprint

Colonic Neoplasms
Guanine
Adenosine Triphosphate
Tissue
Lung
Cells
DNA
Assays
Neoplasms
Reactive Oxygen Species
Nucleotides
Pyrophosphatases
DNA Damage
Colorectal Neoplasms
Diphosphates
Western Blotting
Cytotoxicity
Nucleosides
Tumors
Cell Aging

Keywords

  • 8-oxodGTP
  • Cancer
  • DNA repair
  • Genetic instability
  • MTH1
  • Reactive oxygen species

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

McPherson, L. A., Troccoli, C. I., Ji, D., Bowles, A. E., Gardiner, M. L., Mohsen, M. G., ... Ford, J. M. (2019). Increased MTH1-specific 8-oxodGTPase activity is a hallmark of cancer in colon, lung and pancreatic tissue. DNA Repair, [102644]. https://doi.org/10.1016/j.dnarep.2019.102644

Increased MTH1-specific 8-oxodGTPase activity is a hallmark of cancer in colon, lung and pancreatic tissue. / McPherson, Lisa A.; Troccoli, Clara I.; Ji, Debin; Bowles, Annie E.; Gardiner, Makelle L.; Mohsen, Michael G.; Nagathihalli, Nagaraj S.; Nguyen, Dao M.; Robbins, David J.; Merchant, Nipun B.; Kool, Eric T.; Rai, Priyamvada; Ford, James M.

In: DNA Repair, 01.01.2019.

Research output: Contribution to journalArticle

McPherson, Lisa A. ; Troccoli, Clara I. ; Ji, Debin ; Bowles, Annie E. ; Gardiner, Makelle L. ; Mohsen, Michael G. ; Nagathihalli, Nagaraj S. ; Nguyen, Dao M. ; Robbins, David J. ; Merchant, Nipun B. ; Kool, Eric T. ; Rai, Priyamvada ; Ford, James M. / Increased MTH1-specific 8-oxodGTPase activity is a hallmark of cancer in colon, lung and pancreatic tissue. In: DNA Repair. 2019.
@article{be3fefc662dd403d8609e353a9792564,
title = "Increased MTH1-specific 8-oxodGTPase activity is a hallmark of cancer in colon, lung and pancreatic tissue",
abstract = "Cellular homeostasis is dependent on a balance between DNA damage and DNA repair mechanisms. Cells are constantly assaulted by both exogenous and endogenous stimuli leading to high levels of reactive oxygen species (ROS) that cause oxidation of the nucleotide dGTP to 8-oxodGTP. If this base is incorporated into DNA and goes unrepaired, it can result in G > T transversions, leading to genomic DNA damage. MutT Homolog 1 (MTH1) is a nucleoside diphosphate X (Nudix) pyrophosphatase that can remove 8-oxodGTP from the nucleotide pool before it is incorporated into DNA by hydrolyzing it into 8-oxodGMP. MTH1 expression has been shown to be elevated in many cancer cells and is thought to be a survival mechanism by which a cancer cell can stave off the effects of high ROS that can result in cell senescence or death. It has recently become a target of interest in cancer because it is thought that inhibiting MTH1 can increase genotoxic damage and cytotoxicity. Determining the role of MTH1 in normal and cancer cells is confounded by an inability to reliably and directly measure its native enzymatic activity. We have used the chimeric ATP-releasing guanine-oxidized (ARGO) probe that combines 8-oxodGTP and ATP to measure MTH1 enzymatic activity in colorectal cancer (CRC), non-small cell lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC) along with patient-matched normal tissue. MTH1 8-oxodGTPase activity is significantly increased in tumors across all three tissue types, indicating that MTH1 is a marker of cancer. MTH1 activity measured by ARGO assay was compared to mRNA and protein expression measured by RT-qPCR and Western blot in the CRC tissue pairs, revealing a positive correlation between ARGO assay and Western blot, but little correlation with RT-qPCR in these samples. The adoption of the ARGO assay will help in establishing the level of MTH1 activity in model systems and in assessing the effects of MTH1 modulation in the treatment of cancer.",
keywords = "8-oxodGTP, Cancer, DNA repair, Genetic instability, MTH1, Reactive oxygen species",
author = "McPherson, {Lisa A.} and Troccoli, {Clara I.} and Debin Ji and Bowles, {Annie E.} and Gardiner, {Makelle L.} and Mohsen, {Michael G.} and Nagathihalli, {Nagaraj S.} and Nguyen, {Dao M.} and Robbins, {David J.} and Merchant, {Nipun B.} and Kool, {Eric T.} and Priyamvada Rai and Ford, {James M.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.dnarep.2019.102644",
language = "English (US)",
journal = "DNA Repair",
issn = "1568-7864",
publisher = "Elsevier",

}

TY - JOUR

T1 - Increased MTH1-specific 8-oxodGTPase activity is a hallmark of cancer in colon, lung and pancreatic tissue

AU - McPherson, Lisa A.

AU - Troccoli, Clara I.

AU - Ji, Debin

AU - Bowles, Annie E.

AU - Gardiner, Makelle L.

AU - Mohsen, Michael G.

AU - Nagathihalli, Nagaraj S.

AU - Nguyen, Dao M.

AU - Robbins, David J.

AU - Merchant, Nipun B.

AU - Kool, Eric T.

AU - Rai, Priyamvada

AU - Ford, James M.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Cellular homeostasis is dependent on a balance between DNA damage and DNA repair mechanisms. Cells are constantly assaulted by both exogenous and endogenous stimuli leading to high levels of reactive oxygen species (ROS) that cause oxidation of the nucleotide dGTP to 8-oxodGTP. If this base is incorporated into DNA and goes unrepaired, it can result in G > T transversions, leading to genomic DNA damage. MutT Homolog 1 (MTH1) is a nucleoside diphosphate X (Nudix) pyrophosphatase that can remove 8-oxodGTP from the nucleotide pool before it is incorporated into DNA by hydrolyzing it into 8-oxodGMP. MTH1 expression has been shown to be elevated in many cancer cells and is thought to be a survival mechanism by which a cancer cell can stave off the effects of high ROS that can result in cell senescence or death. It has recently become a target of interest in cancer because it is thought that inhibiting MTH1 can increase genotoxic damage and cytotoxicity. Determining the role of MTH1 in normal and cancer cells is confounded by an inability to reliably and directly measure its native enzymatic activity. We have used the chimeric ATP-releasing guanine-oxidized (ARGO) probe that combines 8-oxodGTP and ATP to measure MTH1 enzymatic activity in colorectal cancer (CRC), non-small cell lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC) along with patient-matched normal tissue. MTH1 8-oxodGTPase activity is significantly increased in tumors across all three tissue types, indicating that MTH1 is a marker of cancer. MTH1 activity measured by ARGO assay was compared to mRNA and protein expression measured by RT-qPCR and Western blot in the CRC tissue pairs, revealing a positive correlation between ARGO assay and Western blot, but little correlation with RT-qPCR in these samples. The adoption of the ARGO assay will help in establishing the level of MTH1 activity in model systems and in assessing the effects of MTH1 modulation in the treatment of cancer.

AB - Cellular homeostasis is dependent on a balance between DNA damage and DNA repair mechanisms. Cells are constantly assaulted by both exogenous and endogenous stimuli leading to high levels of reactive oxygen species (ROS) that cause oxidation of the nucleotide dGTP to 8-oxodGTP. If this base is incorporated into DNA and goes unrepaired, it can result in G > T transversions, leading to genomic DNA damage. MutT Homolog 1 (MTH1) is a nucleoside diphosphate X (Nudix) pyrophosphatase that can remove 8-oxodGTP from the nucleotide pool before it is incorporated into DNA by hydrolyzing it into 8-oxodGMP. MTH1 expression has been shown to be elevated in many cancer cells and is thought to be a survival mechanism by which a cancer cell can stave off the effects of high ROS that can result in cell senescence or death. It has recently become a target of interest in cancer because it is thought that inhibiting MTH1 can increase genotoxic damage and cytotoxicity. Determining the role of MTH1 in normal and cancer cells is confounded by an inability to reliably and directly measure its native enzymatic activity. We have used the chimeric ATP-releasing guanine-oxidized (ARGO) probe that combines 8-oxodGTP and ATP to measure MTH1 enzymatic activity in colorectal cancer (CRC), non-small cell lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC) along with patient-matched normal tissue. MTH1 8-oxodGTPase activity is significantly increased in tumors across all three tissue types, indicating that MTH1 is a marker of cancer. MTH1 activity measured by ARGO assay was compared to mRNA and protein expression measured by RT-qPCR and Western blot in the CRC tissue pairs, revealing a positive correlation between ARGO assay and Western blot, but little correlation with RT-qPCR in these samples. The adoption of the ARGO assay will help in establishing the level of MTH1 activity in model systems and in assessing the effects of MTH1 modulation in the treatment of cancer.

KW - 8-oxodGTP

KW - Cancer

KW - DNA repair

KW - Genetic instability

KW - MTH1

KW - Reactive oxygen species

UR - http://www.scopus.com/inward/record.url?scp=85068767430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068767430&partnerID=8YFLogxK

U2 - 10.1016/j.dnarep.2019.102644

DO - 10.1016/j.dnarep.2019.102644

M3 - Article

C2 - 31311767

AN - SCOPUS:85068767430

JO - DNA Repair

JF - DNA Repair

SN - 1568-7864

M1 - 102644

ER -